Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-malaria antigen and anti-TLR1 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.
There are currently no customer reviews or questions for Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) (BSIG-181). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS